Frances H, Khidichian F
INSERM U. 302, Département de Pharmacologie, Faculté de Médecine, Pitié-Salpétrière, Paris, France.
Eur J Pharmacol. 1990 Apr 10;179(1-2):173-6. doi: 10.1016/0014-2999(90)90415-3.
Eight days of isolation induced in mice a social behavioral deficit responsive to the serotonin agonists, TFMPP (1-(m-trifluoromethylphenyl)piperazine), m-CPP (1-(3-chlorophenyl)piperazine), RU 24969. These drugs are not specific for one subtype of serotonin receptors but share the property of being able to stimulate 5-HT1B receptors. They exert their effects in this test through this receptor. Fluoxetine and phenelzine were behaviorally inactive and did not impair the TFMPP effect when given acutely. On the contrary, the chronic administration of these two antidepressant drugs significantly antagonized the TFMPP effect. These results demonstrate a link between two antidepressant drugs and a function of 5-HT1B receptors. The lack of effect of acute versus chronic treatments suggests the involvement of 5-HT1B receptors in the therapeutic effect of these drugs.
对小鼠进行八天的隔离会诱导出一种对血清素激动剂TFMPP(1-(间三氟甲基苯基)哌嗪)、m-CPP(1-(3-氯苯基)哌嗪)、RU 24969有反应的社会行为缺陷。这些药物并非对血清素受体的某一亚型具有特异性,但都具有能够刺激5-HT1B受体的特性。它们通过该受体在此测试中发挥作用。急性给予氟西汀和苯乙肼时行为上无活性,且不损害TFMPP的作用。相反,长期给予这两种抗抑郁药物会显著拮抗TFMPP的作用。这些结果证明了两种抗抑郁药物与5-HT1B受体功能之间的联系。急性与慢性治疗效果的差异表明5-HT1B受体参与了这些药物的治疗作用。